$ROP

Analysts’ Top Technology Picks: Roper Technologies (ROP), Check Point (CHKP)

Analysts at William Blair and Jefferies reiterated bullish views on Roper Technologies (ROP) and Check Point (CHKP). Becker kept a Buy on ROP; consensus is a Moderate Buy with a $444.43 average target, and a July 8 upgrade set $406. Gallo kept a Buy on CHKP with a $160 target; consensus is $146.76, plus a July 8 upgrade to $164.

Original reporting
Published Jul 24, 2026, 10:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 25, 2026, 6:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Analysts’ Top Technology Picks: Roper Technologies (ROP), Check Point (CHKP) — source image
Decision brief

The 30-second read

$ROPBullishLow
01

Why it matters

For both ROP and CHKP, the actionable content is limited to sentiment and target levels; there is no new operational or financial datapoint from the companies themselves.

02

Market read

Useful for tracking sell-side positioning and potential short-term sentiment flows, but not a standalone fundamental catalyst.

03

What to watch

Price targets can lag fundamentals; traders should verify whether any underlying thesis change (margin, bookings, product cycle) is actually new, which this text does not specify.

Relevance 4/10Novelty 4/10Timing: today’s analyst-rating and price-target updates for ROP and CHKP

Background

The piece is a multi-ticker roundup of two analysts’ bullish calls, including reiterated Buy ratings and stated price targets.

Company-level read

Ticker impact

$ROPBullishMedium confidence
Context

William Blair reiterated a Buy on Roper Technologies and cites a Moderate Buy consensus with a $444.43 average price target.

Expected impact

Near-term trading impact is likely limited to sentiment/positioning around analyst-target headlines.

Evidence & confidence

The only concrete, time-linked items are reiterated/updated analyst ratings and price targets; no earnings, guidance, or company-specific operational catalyst is disclosed.

$CHKPBullishMedium confidence
Context

Jefferies maintained a Buy on Check Point with a $160 price target, alongside a Moderate Buy consensus and an additional July 8 upgrade.

Expected impact

Potential modest support for CHKP shares if traders react to the target changes, but no durable catalyst is provided.

Evidence & confidence

The article provides rating and target figures and prior upgrade references; it lacks new disclosures like earnings, contracts, or regulatory actions.

Market effects

Reinforces positive sell-side sentiment toward parts of the technology sector, but without sector-wide data or policy/regulatory triggers.

No specific regional linkage beyond US-listed tech sentiment.

No global macro or cross-border transaction details are provided.

Counterpoint

Analyst-target articles can be crowded and may not move the stock unless accompanied by new earnings, guidance, or a material catalyst.

Key entities

  • Roper Technologies

    Receives a reiterated Buy rating from William Blair and is described with a Moderate Buy consensus and stated average price target.

  • Check Point

    Receives a maintained Buy rating from Jefferies with a stated price target, plus mention of consensus and a prior upgrade.

Related articles

$CHKPMedAI 9/10

Check Point (CHKP) Q2 2026 Earnings Call Transcript

Check Point (CHKP) reported Q2 2026 revenue of $674M, up 1% YoY, driven by 12% growth in subscription revenue to $333M, while product revenue fell 14%. Non-GAAP EPS was $2.55, up 8%. Deferred revenue rose to $2.025B. Q3 guidance: revenue $665M-$685M, non-GAAP EPS $2.43-$2.53. Management reaffirmed FY2026 outlook and expanded its $2B buyback.

$CHKPMed

Check Point SmartConsole Authentication Bypass Is Under Active Attack, and a PoC Is Now Public

Check Point said active attacks target a SmartConsole authentication bypass in its Security Management and Multi-Domain Management servers. The flaw, CVE-2026-16232 (CVSS 9.3), can let an unauthenticated attacker obtain full admin access to the management plane under specific configurations. Rapid7 published analysis and a public PoC; CISA added the CVE to its Known Exploited list.

$CHKPMedAI 8/10

Check Point Software Technologies Q2 Earnings Call Highlights

Check Point (NASDAQ:CHKP) reported Q2 deferred revenue up 7% to $2.025B and remaining performance obligation up 7% to $2.55B. Current RPO rose 4% to $1.6B. Gross profit was $588M with 87% gross margin. Q3 guidance: revenue $655M-$685M, non-GAAP EPS $2.43-$2.53, adj. FCF $235M-$265M. CEO announced an AI Network Firewall and said sales hiring targets 300 roles for 2027.

$CHKPMed

Mixed results disappoint Check Point’s investors

Check Point Software Technologies (Nasdaq: CHKP) reported Q2 revenue of $674 million, slightly below analysts’ expectations, up 1.3% year over year. Security subscriptions rose to $333 million, but products and licenses fell 14% to $113 million. GAAP net profit was $194 million; non-GAAP profit $264 million, EPS $2.55. Shares fell 6.87% premarket.

$MSFTMed

Microsoft rally offsets Fed jitters; Quanta, Huntington Ingalls gain By Investing.com

U.S. stock index futures rose as Microsoft rallied after a fiscal Q4 2026 earnings beat, with revenue of $90.01B (+18% YoY) and non-GAAP EPS of $4.74. Quanta Services and Huntington Ingalls also gained on better-than-expected results and contract updates. Meta fell after earnings; other movers included Check Point, Capricor, Align, Hyatt, Sirius XM, Trinity, and ImmunityBio.